Cargando…
An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets
Three-levels Box-Behnken design was used in the experimental design approach for the optimization of chromatographic parameters to achieve the optimum resolution and sharp peak shape within a reasonable run time. A method that is sensitive, reliable, and selective was constructed and validated for t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668404/ https://www.ncbi.nlm.nih.gov/pubmed/38001500 http://dx.doi.org/10.1186/s13065-023-01079-x |
_version_ | 1785149123206316032 |
---|---|
author | Mostafa, Eman A. El‐Ashrey, Mohamed K. Mahmoud, Sally Tarek |
author_facet | Mostafa, Eman A. El‐Ashrey, Mohamed K. Mahmoud, Sally Tarek |
author_sort | Mostafa, Eman A. |
collection | PubMed |
description | Three-levels Box-Behnken design was used in the experimental design approach for the optimization of chromatographic parameters to achieve the optimum resolution and sharp peak shape within a reasonable run time. A method that is sensitive, reliable, and selective was constructed and validated for the simultaneous measurement of a combination therapy that contains blood-thinning and cholesterol-lowering compounds. The four cited drugs namely, aspirin (ASP), clopidogrel (CLP), atorvastatin (ATV) and rosuvastatin (ROS) were estimated in bulk and in pharmaceutical dosage forms in line with International Council for Harmonization guidelines. The separation was done utilizing Kinetex 2.6 C18 column (100 mm, 4.6 mm, 5 m) and RP-HPLC with diode array detector. The separation of the cited drugs and the degradation product of ASP was achieved with mobile phase composed of acetonitrile: KH(2)PO(4) buffer in a gradient mode with pH 3.2 at room temperature. The four drugs were linear over the concentration range (0.05–50 µg/mL). The technique is feasible to be used in quality control laboratories. To picture the green profile of the developed method, four greenness assessment tools were applied. National environmental methods index (NEMI), analytical eco-scale assessment (ESA), green analytical procedure index (GAPI) and analytical greenness metric (AGREE) are the most widely used metrics. They were employed to evaluate the greenness profile of the proposed method and to perform a detailed greenness comparison between the developed method and some of the reported methods for the determination of the investigated drugs. The developed method was found to be relatively green with 0.54 AGREE score. |
format | Online Article Text |
id | pubmed-10668404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106684042023-11-24 An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets Mostafa, Eman A. El‐Ashrey, Mohamed K. Mahmoud, Sally Tarek BMC Chem Research Three-levels Box-Behnken design was used in the experimental design approach for the optimization of chromatographic parameters to achieve the optimum resolution and sharp peak shape within a reasonable run time. A method that is sensitive, reliable, and selective was constructed and validated for the simultaneous measurement of a combination therapy that contains blood-thinning and cholesterol-lowering compounds. The four cited drugs namely, aspirin (ASP), clopidogrel (CLP), atorvastatin (ATV) and rosuvastatin (ROS) were estimated in bulk and in pharmaceutical dosage forms in line with International Council for Harmonization guidelines. The separation was done utilizing Kinetex 2.6 C18 column (100 mm, 4.6 mm, 5 m) and RP-HPLC with diode array detector. The separation of the cited drugs and the degradation product of ASP was achieved with mobile phase composed of acetonitrile: KH(2)PO(4) buffer in a gradient mode with pH 3.2 at room temperature. The four drugs were linear over the concentration range (0.05–50 µg/mL). The technique is feasible to be used in quality control laboratories. To picture the green profile of the developed method, four greenness assessment tools were applied. National environmental methods index (NEMI), analytical eco-scale assessment (ESA), green analytical procedure index (GAPI) and analytical greenness metric (AGREE) are the most widely used metrics. They were employed to evaluate the greenness profile of the proposed method and to perform a detailed greenness comparison between the developed method and some of the reported methods for the determination of the investigated drugs. The developed method was found to be relatively green with 0.54 AGREE score. Springer International Publishing 2023-11-24 /pmc/articles/PMC10668404/ /pubmed/38001500 http://dx.doi.org/10.1186/s13065-023-01079-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mostafa, Eman A. El‐Ashrey, Mohamed K. Mahmoud, Sally Tarek An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets |
title | An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets |
title_full | An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets |
title_fullStr | An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets |
title_full_unstemmed | An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets |
title_short | An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets |
title_sort | innovative combination of box-behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668404/ https://www.ncbi.nlm.nih.gov/pubmed/38001500 http://dx.doi.org/10.1186/s13065-023-01079-x |
work_keys_str_mv | AT mostafaemana aninnovativecombinationofboxbehnkendesignandecofriendlyapproachesforthesimultaneousdeterminationofaspirinclopidogrelatorvastatinandrosuvastatinintheirfixeddosecombinationtablets AT elashreymohamedk aninnovativecombinationofboxbehnkendesignandecofriendlyapproachesforthesimultaneousdeterminationofaspirinclopidogrelatorvastatinandrosuvastatinintheirfixeddosecombinationtablets AT mahmoudsallytarek aninnovativecombinationofboxbehnkendesignandecofriendlyapproachesforthesimultaneousdeterminationofaspirinclopidogrelatorvastatinandrosuvastatinintheirfixeddosecombinationtablets AT mostafaemana innovativecombinationofboxbehnkendesignandecofriendlyapproachesforthesimultaneousdeterminationofaspirinclopidogrelatorvastatinandrosuvastatinintheirfixeddosecombinationtablets AT elashreymohamedk innovativecombinationofboxbehnkendesignandecofriendlyapproachesforthesimultaneousdeterminationofaspirinclopidogrelatorvastatinandrosuvastatinintheirfixeddosecombinationtablets AT mahmoudsallytarek innovativecombinationofboxbehnkendesignandecofriendlyapproachesforthesimultaneousdeterminationofaspirinclopidogrelatorvastatinandrosuvastatinintheirfixeddosecombinationtablets |